Unlike China’s debt traps or Russia’s heavy hand, India’s pitch to Central Asia feels like partnership. If Delhi plays it ...

Glenmark will introduce Brukinsa, a BTK inhibitor developed by BeOne Medicines, in India after DCGI approval to treat five ...

Earlier this year, the US lender appointed Vikram Sahu, global head of equity research, as its India country head, and in ...

The MSC IRINA, currently the world's largest container ship by capacity, arrived at the Vizhinjam International Seaport here on Monday morning, port officials said ...

Thailand has closed two border crossings to tourists amid tensions with Cambodia following a deadly clash on May 28 in the ...

The new Covid-19 variant NB.1.8.1 is spreading quickly across India, Asia, and the US. A global virus monitoring body has ...

As India records a rise in COVID-19 cases driven by the JN.1, LF.7, and NB.1.8.1 variants, experts warn of weak surveillance, uneven healthcare access, and the urgent need for long-term disease ...

Zee Entertainment invests in startup Bullet to launch Indian micro-drama app, targeting mobile-first audiences with short-form content.

The India-US deal would provide greater market access for Indian goods by reducing tariffs, cutting trade barriers, and ...

NEW YORK (Reuters) -California's fuel imports rose to the highest in four years in May as refiners turned to historical ...

Seeking their first tournament win, the Indian football team faces a crucial test against Hong Kong in the AFC Asian Cup 2027 ...

Glenmark Pharma Ltd. has announced the launch of a blood cancer treatment drug, marketed globally as Brukinsa, after it secured approval from the Drugs Controller General of India (DCGI).